Abstract
The TAIRE family of kinases are an understudied branch of the CDK kinase family, that have been implicated in a number of cancers. This manuscript describes the design, synthesis and SAR of covalent CDK14 inhibitors, culminating in identification of FMF-04-159-2, a potent, covalent CDK14 inhibitor with a TAIRE kinase biased selectivity profile.
Original language | English |
---|---|
Pages (from-to) | 1985-1993 |
Number of pages | 9 |
Journal | Bioorganic and Medicinal Chemistry Letters |
Volume | 29 |
Issue number | 15 |
DOIs | |
Publication status | Published - 2019 Aug 1 |
Bibliographical note
Publisher Copyright:© 2019 Elsevier Ltd
Keywords
- CDK inhibitor
- CDK14
- CDK15
- CDK16
- CDK17
- CDK18
- Cell cycle
- Covalent kinase inhibitor
- Mitosis
- TAIRE kinase
ASJC Scopus subject areas
- Biochemistry
- Molecular Medicine
- Molecular Biology
- Pharmaceutical Science
- Drug Discovery
- Clinical Biochemistry
- Organic Chemistry